Larvol Delta - PureTechs-Deupirfenidone-LYT100-Demonstrates-Strong-and-Durable-Efcacy-as-a-Monotherapy-with-Favorable-Tolerability-in-Phase-2b-ELEVATE-IPF-Trial

deupirfenidone (LYT-100) - PureTech

https://www.businesswire.com/news/home/20250520345638/en/PureTechs-Deupirfenidone-LYT-100-Demonstrates-Strong-and-Durable-Efficacy-as-a-Monotherapy-with-Favorable-Tolerability-in-Phase-2b-ELEVATE-IPF-Trial

May 20, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next